Related Experiment Video
Updated: May 13, 2026
28:15
Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 28, 2010
[Colorectal carcinogenesis]
Niki Agnantis1, Anna C Goussia
1Chaire d'anatomie pathologique, Faculté de médecine, Université de Ioannina, Grèce. agnantin@gmail.com
Bulletin De L'Academie Nationale De Medecine
|March 12, 2013
Summary
A new pathway in colorectal cancer, known as serrated neoplasia, is identified. This pathway, responsible for 10-15% of cancers, involves distinct molecular features and requires early detection.
Area of Science:
- Gastroenterology and Oncology
- Molecular Pathology
- Cancer Research
Background:
- Colorectal adenocarcinomas were traditionally viewed as a singular entity arising from adenomas.
- Emerging data reveal an alternative pathway of colorectal carcinogenesis termed serrated neoplasia.
- This pathway accounts for an estimated 10% to 15% of sporadic colorectal cancers.
Discussion:
- Serrated lesions exhibit unique histopathological, molecular, and epigenetic characteristics distinct from traditional adenomas.
- Key molecular hallmarks include BRAF gene mutations, CpG island hypermethylation, and microsatellite instability.
- Identifying these serrated precursors is crucial for understanding cancer development.
Key Insights:
- The serrated neoplasia pathway represents a significant alternative route to colorectal cancer.
- Distinct molecular features (BRAF mutations, methylation, MSI) define this pathway.
- Pathologists face challenges in recognizing these precursor lesions for timely intervention.
Outlook:
- Early identification of serrated neoplasia is critical for improved diagnosis and treatment strategies.
- Further research into the molecular mechanisms of serrated pathway cancers is warranted.
- Enhanced diagnostic tools may improve the detection rates of these precursor lesions.
Related Concept Videos
01:25Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...